Mar 29, 2019· Comment from American Pharmacists Association (APhA)· FDA-2018-D-4628-0005
Please see attached for comments from the American Pharmacists Association.
FDANonrulemakingFDA-2018-D-4628
REMS Assessment: Planning and Reporting; Draft Guidance for Industry; Availability
RIN
—
Last modified
Apr 3, 2019
Comment window
closed 2674d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Mar 29, 2019 and Mar 29, 2019. 4 other organizations filed here. The comment window closed 2674d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (4)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Celgene Corporationunverified attribution1 filing · confidence 70%
- International Society of Pharmacoepidemiologytrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%